Key points
- CDC is a leader in the fight against antimicrobial resistance (AR).
- Through its AR Solutions Initiative, CDC works with partners to drive aggressive action and empower the nation to respond to this global threat.
- Check out the stories below that feature solutions in action to combat AR.
CDC Solutions to Combat Antimicrobial Resistance
Panelists discussed building national infrastructure for AR detection & response.
The roles of health departments and public health labs in preventing antimicrobial resistance.
In the December 2024 AMR Exchange, panelists discuss targets from the UN High-level Meeting on AR.
A summary of the AMR Exchange webinar on Impacts of Antimicrobial Resistance on Cancer Care.
Experts discuss a commitment to pursue innovative approaches to utilizing vaccines to help curb AR.
Experts discuss how the Global AR Lab & Response Network strengthens the global fight against AR.
CDC and partners work to help laboratories in Brazil better detect and report critical AR threats.
AR investments in wastewater detection helped protect people from COVID-19.
CDC invests in multi-country projects to help stop spread of resistance.
CDC and health departments work to expand drug-resistant gonorrhea surveillance to emergency rooms.
CDC investments proved to integral in reducing spread of AR and COVID-19 in healthcare facilities.
Experts discuss AR response after COVID-19 through a One Health lens.
CDC and experts worked to estimate the healthcare cost of AR threats in the U.S. annually.
Content Source
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
About This Page
Published: May 15, 2024
Updated: August 12, 2025
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
Reviewed: August 12, 2025
The information on this page was last reviewed by subject matter experts to ensure accuracy.